(DOV) Dover - NYSE
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 29.279m USD | Total Return: 24.1% in 12m
Avg Turnover: 172M
EPS Trend: 88.1%
Qual. Beats: 0
Rev. Trend: -41.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Dover Corporation (NYSE: DOV) is a diversified global manufacturer operating across five primary segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions, and Climate & Sustainability Technologies. The company provides equipment, consumable supplies, and digital solutions for sectors ranging from aerospace and defense to retail fueling and pharmaceutical packaging. As a diversified industrial, Dover operates on a decentralized business model, allowing its various subsidiaries to maintain operational autonomy while leveraging the parent company’s scale.
The company’s portfolio focuses on high-margin aftermarket parts and recurring revenue streams, particularly within its imaging and fluid management divisions. This strategy aligns with broader trends in the Industrial Machinery sub-industry, where manufacturers increasingly integrate software and IoT diagnostics into physical hardware to enhance customer retention. For a deeper look into the companys fundamentals, ValueRay provides comprehensive data tools. Dover’s geographic footprint is global, with its corporate headquarters located in Downers Grove, Illinois.
- Demand for heat exchangers in European residential and commercial HVAC markets
- Biopharma and industrial pump orders drive high-margin segment revenue growth
- Expansion of digital printing and marking solutions in consumer packaging sectors
- Clean energy infrastructure investment fuels cryogenic and hydrogen fueling equipment sales
- Global industrial production levels impact demand across diversified engineered product portfolios
| Net Income: 1.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.94 > 1.0 |
| NWC/Revenue: 26.20% < 20% (prev 31.25%; Δ -5.04% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.37b > Net Income 1.10b |
| Net Debt (1.90b) to EBITDA (1.77b): 1.07 < 3 |
| Current Ratio: 1.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (135.9m) vs 12m ago -1.71% < -2% |
| Gross Margin: 39.50% > 18% (prev 38.91%; Δ 0.59% > 0.5%) |
| Asset Turnover: 63.32% > 50% (prev 61.10%; Δ 2.22% > 0%) |
| Interest Coverage Ratio: 12.38 > 6 (EBIT TTM 1.38b / Interest Expense TTM 111.7m) |
| A: 0.16 (Total Current Assets 4.68b - Total Current Liabilities 2.51b) / Total Assets 13.5b |
| B: 1.07 (Retained Earnings 14.4b / Total Assets 13.5b) |
| C: 0.11 (EBIT TTM 1.38b / Avg Total Assets 13.1b) |
| D: 1.24 (Book Value of Equity 7.49b / Total Liabilities 6.02b) |
| Altman-Z'' = 6.54 = AAA |
| DSRI: 0.98 (Receivables 1.44b/1.38b, Revenue 8.28b/7.73b) |
| GMI: 0.98 (GM 38.91% / 39.50%) |
| AQI: 1.02 (AQ_t 0.57 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 8.28b / 7.73b) |
| TATA: -0.02 (NI 1.10b - CFO 1.37b) / TA 13.5b) |
| Beneish M = -3.00 (Cap -4..+1) = A |
As of June 16, 2026, the stock is trading at USD 220.67 with a total of 566,052 shares traded.
Over the past week, the price has changed by +2.07%,
over one month by +4.95%,
over three months by +6.65% and
over the past year by +24.05%.
Dover has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy DOV.
- StrongBuy: 9
- Buy: 2
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 250.9 | 13.7% |
P/E Trailing = 27.1788
P/E Forward = 20.4499
P/S = 3.5361
P/B = 3.9092
P/EG = 1.8101
Revenue TTM = 8.28b USD
EBIT TTM = 1.38b USD
EBITDA TTM = 1.77b USD
Long Term Debt = 2.60b USD (from longTermDebt, last quarter)
Short Term Debt = 692.8m USD (from shortTermDebt, last quarter)
Debt = 3.54b USD (from shortLongTermDebtTotal, last quarter) + Leases 246.8m
Net Debt = 1.90b USD (calculated: Debt 3.54b - CCE 1.64b)
Enterprise Value = 31.2b USD (29.3b + Debt 3.54b - CCE 1.64b)
Interest Coverage Ratio = 12.38 (Ebit TTM 1.38b / Interest Expense TTM 111.7m)
EV/FCF = 27.40x (Enterprise Value 31.2b / FCF TTM 1.14b)
FCF Yield = 3.65% (FCF TTM 1.14b / Enterprise Value 31.2b)
FCF Margin = 13.74% (FCF TTM 1.14b / Revenue TTM 8.28b)
Net Margin = 13.30% (Net Income TTM 1.10b / Revenue TTM 8.28b)
Gross Margin = 39.50% ((Revenue TTM 8.28b - Cost of Revenue TTM 5.01b) / Revenue TTM)
Gross Margin QoQ = 38.86% (prev 39.10%)
Tobins Q-Ratio = 2.31 (Enterprise Value 31.2b / Total Assets 13.5b)
Interest Expense / Debt = 3.16% (Interest Expense 111.7m / Debt 3.54b)
Taxrate = 20.38% (280.8m / 1.38b)
NOPAT = 1.10b (EBIT 1.38b * (1 - 20.38%))
Current Ratio = 1.87 (Total Current Assets 4.68b / Total Current Liabilities 2.51b)
Debt / Equity = 0.47 (Debt 3.54b / totalStockholderEquity, last quarter 7.49b)
Debt / EBITDA = 1.07 (Net Debt 1.90b / EBITDA 1.77b)
Debt / FCF = 1.67 (Net Debt 1.90b / FCF TTM 1.14b)
Total Stockholder Equity = 7.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.42% (Net Income 1.10b / Total Assets 13.5b)
RoE = 14.69% (Net Income TTM 1.10b / Total Stockholder Equity 7.50b)
RoCE = 13.70% (EBIT 1.38b / Capital Employed (Equity 7.50b + L.T.Debt 2.60b))
RoIC = 9.76% (NOPAT 1.10b / Invested Capital 11.3b)
WACC = 8.74% (E(29.3b)/V(32.8b) * Re(9.49%) + D(3.54b)/V(32.8b) * Rd(3.16%) * (1-Tc(0.20)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -80.90 | Cagr: -1.50%
[DCF] Terminal Value 76.72% ; FCFF base≈909.4m ; Y1≈1.04b ; Y5≈1.53b
[DCF] Fair Price = 146.4 (EV 21.6b - Net Debt 1.90b = Equity 19.7b / Shares 134.7m; r=8.74% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 88.15 | EPS CAGR: 4.64% | SUE: 0.24 | # QB: 0
Revenue Correlation: -41.11 | Revenue CAGR: -1.34% | SUE: 0.65 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.72 | Chg30d=-0.12% | Revisions=+0% | Analysts=18
EPS next Quarter (2026-09-30): EPS=2.90 | Chg30d=+0.07% | Revisions=+33% | Analysts=18
EPS current Year (2026-12-31): EPS=10.63 | Chg30d=-0.03% | Revisions=+20% | GrowthEPS=+10.6% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=11.57 | Chg30d=-0.02% | Revisions=+20% | GrowthEPS=+8.8% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +33%